Results From a Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease From Italian Sites
Abstract
Authors
P Pedrazzoli A Caraceni A Beano V Adamo F Testore A Pigni J Body L Sgreccia E de Cock S Tao P Kritikou G Hechmati F Gatta